Objective/Purpose
To evaluate 3 years outcome of endoscopic cyclophotocoagulation (ECP) in primary open angle glaucoma (POAG)

Materials/Patients
Patients with coexisting cataract and primary open angle glaucoma who underwent phacoemulsification and endoscopic cyclophotocoagulation were included in this retrospective case review.

Methods
72 eyes of 66 patients were included in this study. The patients were excluded if presented a previous ocular history of any intraocular surgery or glaucoma laser treatment. Primary outcome measures included IOP, number of antiglaucoma medications, adverse events and the need for glaucoma procedures.

Results and Conclusion
72 eyes of 66 patients were included in this study. The preoperative IOP was (16.5 ±
4.8 mmHg), The post operative IOP was not significantly lower at any postoperative time point: first month (15.5 ± 5.8 mmHg) (p=0.34), months 3 (15.5 ± 5.2 mmHg) (p=0.10), month 6 (16.4 ± 4.5 mmHg) (p=0.52), month 12 (16.4 ± 5.1) (p=1.0), month 24 (17.4 ± 5.2 mmHg) (p=0.74), and at 36 months (18.7 ± 4.2 mmHg) (p=0.14). The number of preoperative medications (2.9 ± 1.0) decreased significantly (p<0.01) at all time points except month 36 (p= 0.03). The most common complications were: IOP spike > 30 mmHg (9.7%), fibrinous reaction (5.6 %), and RD in one eye (1.4%). 3 eyes needed further surgery to control the IOP. In conclusion, although phacoemulsification combined with endoscopic cyclophotocoagulation for primary open angle glaucoma did not decrease the IOP significantly, yet it is a safe procedure and can significantly decrease the need of antiglaucoma medications.

[ Keyword ]
Glaucoma, Endoscopic cyclophotocoagulation

[ Conflict of Interest ]
No